These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8489771)

  • 1. Morphometric computerized analysis as a method to assess skin atrophy caused by corticosteroids.
    Pelfini C; Vignini M; Calligaro A
    Skin Pharmacol; 1993; 6(1):26-31. PubMed ID: 8489771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Practical application of local corticotherapy: topical corticosteroids].
    Francès C
    Rev Prat; 1990 Feb; 40(6):527-30. PubMed ID: 2320877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Duhring chamber assay for corticosteroid atrophy.
    Frosch PJ; Behrenbeck EM; Frosch K; Macher E
    Br J Dermatol; 1981 Jan; 104(1):57-65. PubMed ID: 7459270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological changes in skin of different phototypes under the action of topical corticosteroid therapy and tacrolimus.
    Shlivko IL; Kamensky VA; Donchenko EV; Agrba P
    Skin Res Technol; 2014 May; 20(2):136-40. PubMed ID: 23808907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of local, persistent cutaneous atrophy following corticosteroid injection with normal saline infiltration.
    Shumaker PR; Rao J; Goldman MP
    Dermatol Surg; 2005 Oct; 31(10):1340-3. PubMed ID: 16188192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local subcutaneous atrophy after corticosteroid injection.
    Jacobs MB
    Postgrad Med; 1986 Sep; 80(4):159-60. PubMed ID: 3763512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of potential skin atrophy following topical application of weak corticosteroids.
    Black MM; Platt NE; Mugglestone CJ
    Curr Med Res Opin; 1981; 7(7):463-70. PubMed ID: 7261664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous mast cell depletion results from topical corticosteroid usage.
    Lavker RM; Schechter NM
    J Immunol; 1985 Oct; 135(4):2368-73. PubMed ID: 4031494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development and regression of dermal corticosteroid atrophy. 1. Change in the skinfold thickness].
    Lubach D; Hinz E
    Derm Beruf Umwelt; 1986; 34(5):146-9. PubMed ID: 2947794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.
    Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():47-51. PubMed ID: 22512680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal experiments investigations on the action of topical corticoids on the normal guinea pig skin.
    Altmeyer P; Sprengart C
    Arch Dermatol Res; 1979 Nov; 266(3):219-225. PubMed ID: 526047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Topical corticosteroid induced changes in the cutaneous basal lamina: scanning electron microscopy study].
    Sheu HM; Yu HS
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Aug; 2(8):502-7. PubMed ID: 3482698
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous atrophy after corticosteroid injection.
    Louis DS; Hankin FM; Eckenrode JF
    Am Fam Physician; 1986 Jan; 33(1):183-6. PubMed ID: 3942046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of corticosteroids.
    Goette DK; Odom RB
    Cutis; 1979 Apr; 23(4):477-87. PubMed ID: 154995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
    Cossmann M; Welzel J
    Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo prevention of corticosteroid-induced skin atrophy by tretinoin in the hairless mouse is accompanied by modulation of collagen, glycosaminoglycans, and fibronectin.
    Schwartz E; Mezick JA; Gendimenico GJ; Kligman LH
    J Invest Dermatol; 1994 Feb; 102(2):241-6. PubMed ID: 8106754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histology of skin changes caused by external corticoid preparations].
    Altmeyer P
    Hautarzt; 1977 Feb; 28(2):83-8. PubMed ID: 403157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of topical ascorbic acid and its effects on photodamaged skin topography.
    Traikovich SS
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1091-8. PubMed ID: 10522500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An appraisal of the methods used in the assessment of atrophy from topical corticosteroids.
    Dykes PJ; Marks R
    Br J Dermatol; 1979 Nov; 101(5):599-609. PubMed ID: 391263
    [No Abstract]   [Full Text] [Related]  

  • 20. The use and abuse of topical corticosteroids in dermatology.
    Hallam NF
    Scott Med J; 1980 Oct; 25(4):287-91. PubMed ID: 7209503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.